VYNE Therapeutics Inc (VYNE)
2.69
+0.12
(+4.67%)
USD |
NASDAQ |
May 10, 16:00
2.69
0.00 (0.00%)
After-Hours: 20:00
VYNE Therapeutics Shareholders Equity (Quarterly): 88.74M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 88.74M |
September 30, 2023 | 11.50M |
June 30, 2023 | 17.27M |
March 31, 2023 | 26.43M |
December 31, 2022 | 31.20M |
September 30, 2022 | 40.07M |
June 30, 2022 | 48.36M |
March 31, 2022 | 55.73M |
December 31, 2021 | 48.64M |
September 30, 2021 | 58.89M |
June 30, 2021 | 74.89M |
March 31, 2021 | 92.90M |
December 31, 2020 | 37.49M |
September 30, 2020 | 49.52M |
Date | Value |
---|---|
June 30, 2020 | 71.53M |
March 31, 2020 | 69.54M |
December 31, 2019 | 68.51M |
September 30, 2019 | 87.00M |
June 30, 2019 | 102.18M |
March 31, 2019 | 115.63M |
December 31, 2018 | 130.38M |
September 30, 2018 | 146.88M |
June 30, 2018 | 158.19M |
March 31, 2018 | 165.70M |
December 31, 2017 | -57.03M |
September 30, 2017 | -47.96M |
December 31, 2016 | -29.44M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
11.50M
Minimum
Sep 2023
102.18M
Maximum
Jun 2019
56.86M
Average
55.73M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
Viking Therapeutics Inc | 933.89M |
AN2 Therapeutics Inc | 124.70M |
NovaBay Pharmaceuticals Inc | 3.314M |
Palatin Technologies Inc | -11.38M |
iBio Inc | 9.197M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 97.68M |
Total Liabilities (Quarterly) | 8.95M |
Current Ratio | 12.73 |